Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins

Biochemical Society Transactions

Volumn 44, Issue 2, 2016, Pages 568-573

  Hay, Debbie L ^a   Walker, Christopher S ^a   Gingell, Joseph J ^a   Ladds, Graham ^b   Reynolds, Christopher A ^c   Poyner, David R ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF ESSEX   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

Adrenomedullin; Amylin; Calcitonin gene related peptide (CGRP); Calcitonin receptor; Calcitonin receptor like receptor; Family B G protein coupled receptor; Receptor activity modifying protein (RAMP)

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2;

CELL MIGRATION; CELL SURFACE; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; PROTEIN CONFORMATION; RECEPTOR ACTIVITY-MODIFYING PROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85009877618     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150237     Document Type: Review

References (44)

1. McLatchie, L.M., Fraser, N.J., Main, M.J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M.G. and Foord, S.M. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339
2. Barwell, J., Gingell, J.J., Watkins, H.A., Archbold, J.K., Poyner, D.R. and Hay, D.L. (2012) Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br. J. Pharmacol. 166, 51-65
3. Kusano, S. and Yokoyama, S. (2013) Ectodomain structures of the CGRP and AM receptors. Curr. Protein Pept. Sci. 14, 375-385
4. Hay, D.L. and Pioszak, A.A. (2016) Receptor activity modifying proteins: new insights and roles. Annu. Rev. Pharmacol. Toxicol. 56, 469-487
5. Kusano, S., Kukimoto-Niino, M., Akasaka, R., Toyama, M., Terada, T., Shirouzu, M., Shindo, T. and Yokoyama, S. (2008) Crystal structure of the human receptor activity-modifying protein 1 extracellular domain. Protein Sci. 17, 1907-1914
6. Kusano, S., Kukimoto-Niino, M., Hino, N., Ohsawa, N., Okuda, K.I., Sakamoto, K., Shirouzu, M., Shindo, T. and Yokoyama, S. (2012) Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding. Protein Sci. 21, 199-210
7. ter Haar, E., Koth, C.M., Abdul-Manan, N., Swenson, L., Coll, J.T., Lippke, J.A., Lepre, C.A., Garcia-Guzman, M. and Moore, J.M. (2010) Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18, 1083-1093
8. Booe, J.M., Walker, C.S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M.A., Warner, M.L., Bill, R.M., Harris, P.W., Brimble, M.A. et al. (2015) Structural basis for receptor activity-modifying protein-dependent selective peptide recognition by a G protein-coupled receptor. Mol. Cell 58, 1040-1052
9. Qi, T., Simms, J., Bailey, R.J., Wheatley, M., Rathbone, D.L., Hay, D.L. and Poyner, D.R. (2010) Structure-function analysis of RAMP1-RAMP3 chimeras. Biochemistry 49, 522-531
10. Moore, E.L. and Salvatore, C.A. (2012) Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. Br. J. Pharmacol. 166, 66-78
11. Hoare, S.R. (2005) Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov. Today 10, 417-427
12. Moad, H.E. and Pioszak, A.A. (2013) Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins. Protein Sci. 22, 1775-1785
13. Watkins, H.A., Au, M., Bobby, R., Archbold, J.K., Abdul-Manan, N., Moore, J.M., Middleditch, M.J., Williams, G.M., Brimble, M.A., Dingley, A.J. and Hay, D.L. (2013) Identification of key residues involved in adrenomedullin binding to the AM1 receptor. Br. J. Pharmacol. 169, 143-155
14. Rist, B., Entzeroth, M. and Beck-Sickinger, A.G. (1998) From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. J. Med. Chem. 41, 117-123
15. Archbold, J.K., Flanagan, J.U., Watkins, H.A., Gingell, J.J. and Hay, D.L. (2011) Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends Pharmacol. Sci. 32, 591-600
16. Grace, C.R., Perrin, M.H., Gulyas, J., Digruccio, M.R., Cantle, J.P., Rivier, J.E., Vale, W.W. and Riek, R. (2007) Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand. Proc. Natl. Acad. Sci. U.S.A. 104, 4858-4863
17. Koth, C.M., Abdul-Manan, N., Lepre, C.A., Connolly, P.J., Yoo, S., Mohanty, A.K., Lippke, J.A., Zwahlen, J., Coll, J., Doran, J.D. et al. (2010) Refolding and in vitro characterization of a soluble antagonist binding domain of the CGRP receptor. Biochemistry 49, 1862-1872
18. Yang, L., Yang, D., de Graaf, C., Moeller, A., West, G.M., Dharmarajan, V., Wang, C., Siu, F.Y., Song, G., Reedtz-Runge, S. et al. (2015) Conformational states of the full-length glucagon receptor. Nat. Commun. 6, 7859
19. Watkins, H.A., Walker, C.S., Ly, K.N., Bailey, R.J., Barwell, J., Poyner, D.R. and Hay, D.L. (2014) Receptor activity-modifying protein dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology. Br. J. Pharmacol. 171, 772-778
20. Watkins, H.A., Abhayawardana, R.S., Chakravarthy, M., Barwell, J., Woolley, M.J., Conner, A.C., Poyner, D.R. and Hay, D.L. (2013) Investigation of effects on adrenomedullin pharmacology of mutations in the upper transmembrane/extracellular loop region of the calcitonin receptor-like receptor., Proceedings of the British Pharmacological Society at http://www.pA2online.org/abstracts/Vol11Issue3abst102P.pdf
21. Fitzsimmons, T.J., Zhao, X. and Wank, S.A. (2003) The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function. J. Biol. Chem. 278, 14313-14320
22. Kuwasako, K., Kitamura, K., Nagata, S., Nozaki, N. and Kato, J. (2012) Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization. Biochem. Biophys. Res. Commun. 420, 582-587
23. Kuwasako, K., Kitamura, K., Nagata, S. and Kato, J. (2009) Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins. Biochem. Biophys. Res. Commun. 384, 249-254
24. Harikumar, K.G., Simms, J., Christopoulos, G., Sexton, P.M. and Miller, L.J. (2009) Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor. Biochemistry 48, 11773-11785
25. Harikumar, K.G., Morfis, M.M., Sexton, P.M. and Miller, L.J. (2008) Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor. J. Mol. Neurosci. 36, 279-285
26. Udawela, M., Christopoulos, G., Tilakaratne, N., Christopoulos, A., Albiston, A. and Sexton, P.M. (2006) Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors. Mol. Pharmacol. 69, 1984-1989
27. Udawela, M., Christopoulos, G., Morfis, M., Tilakaratne, N., Christopoulos, A. and Sexton, P.M. (2008) The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors. Regul. Pept. 145, 65-71
28. Bomberger, J.M., Spielman, W.S., Hall, C.S., Weinman, E.J. and Parameswaran, N. (2005) Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1. J. Biol. Chem. 280, 23926-23935
29. Christopoulos, G., Perry, K.J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N.J., Main, M.J., Foord, S.M. and Sexton, P.M. (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56, 235-242
30. Hay, D.L., Chen, S., Lutz, T.A., Parkes, D.G. and Roth, J.D. (2015) Amylin: pharmacology, physiology, and clinical potential. Pharmacol. Rev. 67, 564-600
31. Morfis, M., Tilakaratne, N., Furness, S.G., Christopoulos, G., Werry, T.D., Christopoulos, A. and Sexton, P.M. (2008) Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors. Endocrinology 149, 5423-5431
32. Bouschet, T., Martin, S. and Henley, J.M. (2005) Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J. Cell Sci. 118, 4709-4720
33. Lenhart, P.M., Broselid, S., Barrick, C.J., Leeb-Lundberg, L.M. and Caron, K.M. (2013) G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J. Mol. Endocrinol. 51, 191-202
34. Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N. and Sexton, P.M. (2003) Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278, 3293-3297
35. Heroux, M., Hogue, M., Lemieux, S. and Bouvier, M. (2007) Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. J. Biol. Chem. 282, 31610-31620
36. Wootten, D., Lindmark, H., Kadmiel, M., Willcockson, H., Caron, K.M., Barwell, J., Drmota, T. and Poyner, D.R. (2013) Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function. Br. J. Pharmacol. 168, 822-834
37. Weston, C., Lu, J., Li, N., Barkan, K., Richards, G.O., Roberts, D.J., Skerry, T.M., Poyner, D., Pardamwar, M., Reynolds, C.A. et al. (2015) Modulation of glucagon receptor pharmacology by receptor activity-modifying protein-2 (RAMP2). J. Biol. Chem. 290, 23009-23022
38. Kadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G.O., Li, M., Skerry, T.M. and Caron, K.M. (2011) Research resource: haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol. Endocrinol. 25, 1244-1253
39. Zhang, Z., Dickerson, I.M. and Russo, A.F. (2006) CGRP receptor activation by RAMP1 gene transfer to vascular smooth muscle cells. Endocrinology 147, 1932-1940
40. Zhang, Z., Winborn, C.S., Marquez de Prado, B. and Russo, A.F. (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J. Neurosci. 27, 2693-2703
41. Chrissobolis, S., Zhang, Z., Kinzenbaw, D.A., Lynch, C.M., Russo, A.F. and Faraci, F.M. (2010) Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke 41, 2329-2334
42. Buhlmann, N., Leuthauser, K., Muff, R., Fischer, J.A. and Born, W. (1999) A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 140, 2883-2890
43. Hilairet, S., Belanger, C., Bertrand, J., Laperriere, A., Foord, S.M. and Bouvier, M. (2001) Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin. J. Biol. Chem. 276, 42182-42190
44. Muller, J.M., Debaigt, C., Goursaud, S., Montoni, A., Pineau, N., Meunier, A.C. and Janet, T. (2007) Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update. Peptides 28, 1655-1666